securities fraud

Corcept Therapeutics faces securities class action after FDA rejected relacorilant, causing 50% stock collapse. Investors have until April 21 to file claims.

Kahn Swick & Foti, LLC filed class action suits against Gemini Space Station over alleged cryptocurrency platform misstatements. Investors must apply by May 18, 2026.

Apollo Global Management faces securities fraud suit over undisclosed Epstein communications with executives. Stock declined 16% during class period ending February 2026.

Robbins LLP files class action against $ATRA over undisclosed manufacturing issues tied to FDA rejection of lead drug tabelecleucel, citing 57% stock plunge.

Robbins LLP filed a class action lawsuit against $PSIX after stock collapsed 29% on weak margin guidance, alleging investor deception about data center demand and manufacturing efficiency.

Robbins LLP sued Hercules Capital for allegedly overstating due diligence and misclassifying portfolio investments, triggering a 7.9% stock decline following damaging media report.

$CIGL stock collapsed 94% from $31.06 peak after alleged pump-and-dump fraud scheme. Robbins LLP investigates impersonated advisors, social media misinformation. Class action available for April-July 2025 buyers.

Law firm Kirby McInerney investigates $ADMA for potential securities violations. Culper Research alleges channel stuffing and undisclosed related-party distribution practices inflated 2025 growth.

Aldeyra Therapeutics stock plummets 71% following FDA rejection of reproxalap for dry eye disease. Class action lawsuit filed; investor deadline May 29, 2026.

Pomerantz LLP sues Soleno Therapeutics ($SLNO) over alleged securities fraud as stock plummets 39% following DCCR safety concerns and patient death disclosure. Lead Plaintiff deadline: May 5, 2026.

Pomerantz Law Firm investigates $EVTL for potential securities fraud following going concern disclosure that sparked 18.18% stock decline.

Pomerantz LLP investigates Banco Santander for potential securities fraud over undisclosed exposure to collapsed UK mortgage lender. $SAN shares fell 7.57% to $11.96 on February 28, 2026.

Driven Brands faces class action lawsuit over material accounting restatements spanning 2023-2025. Stock fell 30.16%; investors must join suit by May 11, 2026.

Pomerantz LLP files securities fraud class action against Camping World Holdings ($CWH) following disclosure of declining revenues, margin compression, and dividend suspension. Investors must act by May 11, 2026.

NuScale Power faces securities fraud lawsuit over undisclosed $495M payment; deadline April 20, 2026.

Pomerantz Law Firm files securities fraud suit against PayPal after disappointing Q4 earnings, CEO exit, and 2027 guidance withdrawal. Investors have until April 20, 2026, for Lead Plaintiff status.

Kyndryl Holdings stock crashes 55% following SEC investigation disclosure and three executive departures. Class action filed; investor deadline April 13, 2026.

Class action lawsuit alleges $ORCL concealed massive CapEx increases and associated risks amid AI infrastructure expansion, following analyst downgrades and disappointing results.

$QURE plummeted 49% after FDA feedback on AMT-130 gene therapy. Pomerantz Law Firm filed class action lawsuit; investor deadline April 13, 2026.

Pomerantz Law Firm files securities fraud lawsuit against $MREO after failed Phase 3 trials tank stock 87.7%. Lead Plaintiff deadline: April 6, 2026.